Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-013882
Filing Date
2012-03-02
Accepted
2012-03-02 16:38:32
Documents
1
Period of Report
2012-02-29

Document Format Files

Seq Description Document Type Size
1 rrd336491.html 4  
1 rrd336491.xml 4 4054
  Complete submission text file 0001181431-12-013882.txt   5384
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Issuer) CIK: 0001310094 (see all company filings)

EIN.: 000000000 | State of Incorp.: FL | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14431 25TH AVENUE, SW SEATTLE WA 98166
Business Address
SCHUBERT DAVID M (Reporting) CIK: 0001319909 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51383 | Film No.: 12663434